Renrong Wu, MD, PhD, is affiliated with the Department of Psychiatry and the National Clinical Research Center for Mental Disorders at The Second Xiangya Hospital of Central South University in Changsha, P. R. China. Wu has published research focused on schizophrenia and schizoaffective disorders, including studies on the efficacy and safety of adjunctive treatments such as sulforaphane and quetiapine-XR in managing symptoms. Wu's work, published between 2014 and 2025, often explores pharmacological interventions for complex psychiatric conditions.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
